Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ian Mortimer currently holds 49,923 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ian Mortimer has been a net seller of XENE stock. They have purchased $1.2M and sold $3.9M worth of shares.
Ian Mortimer's most recent insider trade was on Sep 30, 2026, when they purchased 30,000 shares at $37.38 per share.
Ian Mortimer serves as Executive at Xenon Pharmaceuticals Inc. (XENE). They have executed 26 insider transactions totaling $5.1M over their tenure at the company.
Ian Mortimer holds the position of Executive at Xenon Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Ian Mortimer has shown a selling trading pattern, with $1.2M in total purchases and $3.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ian Mortimer was on Sep 30, 2026, when they purchased $1.1M worth of XENE shares. This transaction involved 30,000 shares at $37.38 per share.
Ian Mortimer currently owns 49,923 shares of Xenon Pharmaceuticals Inc. (XENE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ian Mortimer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ian Mortimer has 26 Form 4 filings on record as an insider at Xenon Pharmaceuticals Inc..
Set alerts for Ian Mortimer and 40,000+ other insiders.